Global Desalting and Buffer Exchange Market Size study & Forecast, by Product (Kit, Cassette & Cartridge, Spin Columns), by Technique (Size Exclusion Chromatography, Filtration, Dialysis), by Application (Bioprocess (Pharmaceutical Companies, Research Ins

The Global Desalting and Buffer Exchange Market, valued at approximately USD 1.2 billion in 2024, is projected to expand at a remarkable CAGR of 10.00% during the forecast period from 2025 to 2035. Desalting and buffer exchange are critical processes in the purification and preparation of biological samples, enabling the removal of low-molecular-weight contaminants and the replacement of solutions for optimal downstream applications. These methods are indispensable across pharmaceutical manufacturing, protein research, and biotechnology workflows, as they directly impact product purity, stability, and efficacy. As the life sciences sector continues to prioritize efficiency and reproducibility, there has been an accelerated shift towards advanced kits, cassettes, and spin columns that offer faster processing times, higher recovery rates, and scalability for both small- and large-volume operations. The growing demand for biologics, particularly monoclonal antibodies, vaccines, and cell-based therapies, is further amplifying the need for precise desalting and buffer exchange techniques to ensure compliance with stringent quality standards.

The market growth is further fueled by the pharmaceutical industry’s heightened focus on bioprocess optimization and the increasing volume of R&D activities in drug discovery. Advanced desalting and buffer exchange methods such as size exclusion chromatography, ultrafiltration, and dialysis are becoming mainstays in protein purification pipelines, enabling researchers to achieve superior yield without compromising sample integrity. According to industry estimates, global biologics production has witnessed double-digit growth over the past decade, with contract development and manufacturing organizations (CDMOs) rapidly integrating automated and high-throughput desalting platforms to meet the surge in demand. Moreover, the increasing prevalence of chronic diseases—driving the need for biologically derived therapeutics—has spurred investment in bioprocessing infrastructure, creating a fertile ground for market expansion. However, the high cost of specialized equipment and the technical expertise required for process optimization may present challenges for smaller laboratories and emerging biotech firms.

Regionally, North America is expected to command the largest share of the desalting and buffer exchange market in 2025, owing to its robust biotechnology ecosystem, substantial investments in pharmaceutical R&D, and the presence of leading biopharmaceutical companies. The region benefits from a mature regulatory framework and a strong network of academic and research institutions that continuously drive innovation in bioprocess technologies. Europe follows closely, with its expanding biosimilars market and government-backed initiatives promoting advanced biomanufacturing capabilities. Meanwhile, Asia Pacific is forecast to experience the fastest growth through 2035, propelled by rapid industrialization, increasing healthcare expenditure, and a surge in biologics manufacturing across countries such as China, India, and South Korea. These nations are not only expanding their domestic capabilities but are also becoming preferred outsourcing hubs for global pharmaceutical giants, thereby boosting regional demand for desalting and buffer exchange solutions.

Major market player included in this report are:
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Cytiva (Danaher Corporation)
• Agilent Technologies, Inc.
• Sartorius AG
• Repligen Corporation
• Waters Corporation
• Pall Corporation
• Purolite Corporation
• Tosoh Bioscience LLC
• PerkinElmer, Inc.
• Avantor, Inc.
• Shimadzu Corporation
• GE Healthcare

Global Desalting and Buffer Exchange Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Kit
• Cassette & Cartridge
• Spin Columns

By Technique:
• Size Exclusion Chromatography
• Filtration
• Dialysis

By Application:
• Bioprocess

  • Pharmaceutical Companies

  • Research Institutes

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more